Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-11-01 / Cancer Res. 2004 Nov;64(21):8022-8Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
/in Dendritic Cells, Glioblastoma, International Publications /von 2004-11-01 / J. Immunother. 2004 Nov-Dec;27(6):452-9Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2004-09-27 / J. Clin. Oncol. 2004 Nov;22(21):4272-81Dendritic cell-based immunotherapy in thyroid malignancies
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2004-09-01 / Curr. Drug Targets Immune Endocr. Metabol. Disord. 2004 Sep;4(3):245-51Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
/in Dendritic Cells, Glioblastoma, International Publications /von 2004-08-15 / Clin. Cancer Res. 2004 Aug;10(16):5316-26Therapeutic cancer vaccines: using unique antigens
/in Dendritic Cells, Hyperthermia, International Publications /von 2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-6Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-07-15 / Clin. Cancer Res. 2004 Jul;10(14):4699-708Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2004-07-15 / Cancer Res. 2004 Jul;64(14):4973-9Autologous dendritic cell vaccines for non-small-cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2004-07-15 / J. Clin. Oncol. 2004 Jul;22(14):2808-15
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de